Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jennifer Cnops
Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study
PLoS ONE
Multidisciplinary
Related publications
A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)
PLoS ONE
Multidisciplinary
Lidocaine for Systemic Sclerosis: A Double-Blind Randomized Clinical Trial
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial
Neurology
Neurology
A Selective Neurokinin-1 Receptor Antagonist in Chronic PTSD: A Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Trial
European Neuropsychopharmacology
Psychiatry
Mental Health
Neurology
Biological Psychiatry
Pharmacology
Double Blind Study of Intrathecal Beta-Interferon in Multiple Sclerosis: Clinical and Laboratory Results.
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Multiple Sclerosis: Longitudinal Measurement of Interleukin-1 Receptor Antagonist.
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
A Randomized Double Blind Study of a Green and Black Tea Agent, AssuriTEA®, in Healthy Male Subjects
Functional Foods in Health and Disease
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis
Kidney International Reports
Nephrology
Eptinezumab in Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study (PROMISE-1)
Cephalalgia
Medicine
Neurology
